|
CN112184602A
|
|
Image normalization method based on weak supervision and auxiliary task
|
|
CN111938671A
|
|
Anxiety trait quantification method based on multi-dimensional internal perception features
|
|
CN111403032A
|
|
Child brain development level assessment method, system and storage device
|
|
CN111000571A
|
|
Method for predicting risk of post-traumatic psychological disease, related device and storage device
|
|
CN110910513A
|
|
Augmented reality system for assisting examinee in adapting to magnetic resonance scanning environment
|
|
CN110911013A
|
|
Schizophrenia auxiliary diagnosis method based on painting and drawing
|
|
CN110903517A
|
|
Edible test paper for measuring psychological pressure and preparation method thereof
|
|
CN110866434A
|
|
Facial expression recognition training method and system for autism patient
|
|
CN110459327A
|
|
A kind of self-closing disease stereotypic behavior analysis method and system based on deep learning
|
|
CN110288986A
|
|
Online cognition self-appraisal voice system and its processing method
|
|
CN109999348A
|
|
A method of transcranial magnetic stimulation deep brain area is realized based on diffusion tensor
|
|
CN110010245A
|
|
A kind of mental disease brain image processing system
|
|
CN109718236A
|
|
Application of the bulleyaconitine A in preparation treatment irritable bowel syndrome drug
|
|
CN109903604A
|
|
A kind of neurodevelopmental disorder drawing training system and training method based on virtual reality
|
|
CN109939325A
|
|
A kind of neurodevelopmental disorder music training system based on virtual reality technology
|
|
CN109432308A
|
|
A kind of Chinese medicine composition of extrapyramidal system side reaction caused by improvement antipsychotics and its application
|
|
CN109316196A
|
|
Amphetamines based on virtual reality joint eeg monitoring crave for appraisal procedure
|
|
CN109055541A
|
|
MCI diagnosis marker and its application caused by AD
|
|
CN108982714A
|
|
A kind of method that simple and effective detects human plasma Venlafaxine and its active metabolite O-Goven Wenfasin concentration
|
